Tracer library / [177Lu]Lu-DOTA-FAPI-04
Structure of DOTA-FAPI-04 (unlabelled parent compound, from PubChem)
Unlabelled parent compoundPubChem CID 138454803

[177Lu]Lu-DOTA-FAPI-04

Also written as [Lu-177]Lu-DOTA-FAPI-04
Radionuclide
Lu-177 t½ 9584.6 min
Modality
Therapy
Production route
—
Stage
Preclinical
Syntheses indexed
0
Preclinical only, no clinical indication yetFibroblast activation / tumour stroma

What it is

Compound class
FAP inhibitor (FAPI)-based radiopharmaceutical
Target / mechanism
Fibroblast activation protein (FAP) PMID 41934690
Clinical application
—
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [177Lu]Lu-DOTA-FAPI-04, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Stage set/updated at stage 39 from PMID 41934690: 'higher specific binding ability toward FAP-positive cancer cells over widely-used 177Lu-DOTA-FAPI-04'.
Ask a question